oninvasive Assessement of Liver Fat in a Donor Liver
Phase 2
- Conditions
- Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified
- Registration Number
- CTRI/2021/01/030223
- Lead Sponsor
- Mohamed Rela
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 49
Inclusion Criteria
1. Age above 18 years
2. Deceased donor and live donor livers selected for donation
Exclusion Criteria
1. Age below 18 years
2. Liver where frozen section/ standard biopsy cannot be taken
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Validation of Real-time assessment of liver steatosis by Spectroscopy compared to frozen section/standard liver biopsy by assessing Outcome of liver transplantation using the liver assessed by spectroscopyTimepoint: 1. Day 0 - liver biopsy status <br/ ><br>2. Day 0 - Outcome of transplanting the liver- absence of primary non function, output of bile <br/ ><br>Day 14 - Morbidity and mortality <br/ ><br>Day 30 - Morbidity and mortality <br/ ><br>Day 90 - Morbidity and Mortality
- Secondary Outcome Measures
Name Time Method Assessment of Using the donor liver in outcomes of the liver transplantation in RecipientTimepoint: 3 month mortality